Activity of human IgG and IgA subclasses in immune defense against Neisseria meningitidis serogroup B1

Journal of Immunology

Volumn 166, Issue 10, 2001, Pages 6250-6256

  Vidarsson, Gestur ^a   Van Der Pol, W Ludo ^a   Van Den Elsen, Jean M H ^c   Vilé, Henriëtte ^a   Jansen, Marc ^a   Duijs, Jacques ^d   Morton, H Craig ^e   Boel, Edwin ^b   Daha, Mohamed R ^d   Corthésy, Blaise ^f   Van De Winkel, Jan G J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF TORONTO   (Canada)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF OSLO   (Norway)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PORIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL STRAIN BHK; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; IMMUNOGLOBULIN GENE; LEUKOCYTE ACTIVATION; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY BURST;

EID: 18344406350     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.10.6250     Document Type: Article

References (42)

1. Goldschneider, I., E. C. Gotschlich, and M. Artenstein. 1969. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129:1307.
2. Goldschneider, I., E. C. Gotschlich, and M. Artenstein. 1969. Human immunity to the meningococcus. II. Development of natural immunity. J. Exp. Med. 129: 1327.
3. Peltola, H., A. Safary, H. Kayhty, V. Karanko, and F. E. Andre. 1985. Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children: a clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides. Pediatrics 76:91.
4. 197 conjugate vaccine. Infect. Immun. 65:1710.
5. Bjune, G., E. A. Hoiby, J. K. Gronnesby, O. Arnesen, J. H. Fredriksen, A. Halstensen, E. Holten, A. K. Lindbak, H. Nokleby, E. Rosenqvist, et al. 1991. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338:1093.
6. Finne, J., M. Leinonen, and P. H. Makela. 1983. Antigenic similarities between brain components and bacteria causing meningitis: implications for vaccine development and pathogenesis. Lancet 2:355.
7. van der Voort, E. R., M. Schuller, J. Holst, P. de Vries, P. van der Ley, G. van den Dobbelsteen, and J. Poolman. 2000. Immunogenicity studies with a genetically engineered hexavalent PorA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys. Vaccine 18: 1334.
8. Ravetch, J. V. 1997. Fc receptors. Curr. Opin. Immunol. 9:121.
9. Vidarsson, G., and J. G. J. van de Winkel. 1998. Fc receptor and complement receptor-mediated phagocytosis in host defence. Curr. Opin. Infect. Dis. 11:271.
10. Morton, H. C., M. van Egmond, and, J. G. J. van de Winkel. 1996. Structure and function of human IgA Fc receptors (FcαR). Crit. Rev. Immunol. 16:423.
11. Bredius, R. G., B. H. Derkx, C. A. Fijen, T. P. de Wit, M. de Haas, R. S. Weening, J. G. J. van de Winkel, and T. A. Out. 1994. Fc γ receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J. Infect. Dis. 170:848.
12. Aase, A., and T. E. Michaelsen. 1994. Opsonophagocytic activity induced by chimeric antibodies of the four human IgG subclasses with or without help from complement. Scand. J. Immunol. 39:581.
13. Ross, C., P. J. Rosenthal, H. M. Berberich, and P. Densen. 1987. Killing of Neisseria meningitidis by human neutrophils: implications for normal and complement-deficient individuals. J. Infect. Dis. 155:1266.
14. Griffiss, J. M., D. D. Broud, and M. A. Bertram. 1975. Bactericidal activity of meningococcal antisera: blocking by IgA of lytic antibody in human convalescent sera. J. Immunol. 114:1779.
15. Lowell, G. H., L. F. Smith, J. M. Griffiss, and B. L. Brandt. 1980. IgA-dependent, monocyte-mediated, antibacterial activity. J. Exp. Med. 152:452.
16. Lehmann, A. K., A. Halstensen, I. S. Aaberge, J. Holst, T. E. Michaelsen, S. Sornes, L. M. Wetzler, and H. Guttormsen. 1999. Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB. Infect. Immun. 67:2552.
17. van den Elsen, J. M., L. Vandeputte-Rutten, J. Kroon, and P. Gros. 1999. Bactericidal antibody recognition of meningococcal PorA by induced fit: comparison of liganded and unliganded Fab structures. J. Biol. Chem. 274:1495.
18. van den Elsen, J. M., J. N. Herron, P. Hoogerhout, J. T. Poolman, E. Boel, T. Logtenberg, J. Wilting, D. J. Crommelin, J. Kroon, and P. Gros. 1997. Bactericidal antibody recognition of a PorA epitope of Neisseria meningitidis: crystal structure of a Fab in complex with a fluorescein-conjugated peptide. Proteins 29:113.
19. Vidarsson, G., J. G. J. van De Winkel, and M. A. van Dijk. 2001. Multiplex screening for functionally-rearranged Immunoglobulin variable regions reveals expression of hybridoma-specific aberrant V-genes. J. Immunol. Methods 249: 245.
20. Boel, E., S. Verlaan, M. J. Poppelier, N. A. Westerdaal, J. A. Van Strijp, and T. Logtenberg. 2000. Functional human monoclonal antibodies of all isotypes constructed from phage display library-derived single-chain Fv antibody fragments. J. Immunol. Methods 239:153.
21. Kimura, N., B. Toyonaga, Y. Yoshikai, R. P. Du, and T. W. Mak. 1987. Sequences and repertoire of the human T cell receptor α and β chain variable region genes in thymocytes. Eur. J. Immunol. 17:375.
22. Huls, G. A., I. A. Heijnen, M. E. Cuomo, J. C. Koningsberger, L. Wiegman, E. Boel, A. R. van der Vuurst de Vries, S. A. Loyson, W. Helfrich, G. P. van Berge Henegouwen, et al. 1999:A recombinant, fully human monoclonal antibody with antitumor activity constructed from phage-displayed antibody fragments. Nat. Biotechnol. 17:276.
23. Berdoz, J., C. T. Blanc, M. Reinhardt, J. P. Kraehenbuhl, and B. Corthesy. 1999. In vitro comparison of the antigen-binding and stability properties of the various molecular forms of IgA antibodies assembled and produced in CHO cells. Proc. Natl. Acad. Sci. USA 96:3029.
24. Stowell, K. M., T. A. Rado, W. D. Funk, and J. W. Tweedie. 1991. Expression of cloned human lactoferrin in baby-hamster kidney cells. Biochem. J. 276:349.
25. Belew, M., N. Juntti, A. Larsson, and J. Porath. 1987. A one-step purification method for monoclonal antibodies based on salt-promoted adsorption chromatography on a "thiophilic" adsorbent. J. Immunol. Methods 102:173.
26. van der Pol, W. L., and J. G. J. van de Winkel. 1998. IgG receptor polymorphisms: risk factors for disease. Immunogenetics 48:222.
27. Schmitz, F. J., K. E. Veldkamp, K. P. Van Kessel, J. Verhoef, and J. A. Van Strijp. 1997. Delta-toxin from Staphylococcus aureus as a costimulator of human neutrophil oxidative burst. J. Infect. Dis. 176:1531.
28. Chintalacharuvu, K. R., and S. L. Morrison. 1997. Production of secretory immunoglobulin A by a single mammalian cell. Proc. Natl. Acad. Sci. USA 94: 6364.
29. Rodriguez, M. E., W. L. Van der Pol, L. A. Sanders, and J. G. J. Van de Winkel. 1999. Crucial role of FcγRIIa (CD32) in assessment of functional anti-Streptococcus pneumoniae antibody activity in human sera. J. Infect. Dis. 179:423.
30. Corthesy, B., and F. Spertini. 1999. Secretory immunoglobulin A: from mucosal protection to vaccine development. Biol. Chem. 380:1251.
31. Bruggemann, M., G. T. Williams, C. I. Bindon, M. R. Clark, M. R. Walker, R. Jefferis, H. Waldmann, and M. S. Neuberger. 1987. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J. Exp. Med. 166:1351.
32. Hiemstra, P. S., A. Goner, M. E. Stuurman, L. A. Van Es, and M. R. Daha. 1987. Activation of the alternative pathway of complement by human serum IgA. Eur. J. Immunol. 17:321.
33. Burton, D. R., and J. M. Woof. 1992. Human antibody effector function. Adv. Immunol. 51:1.
34. Hamadeh, R. M., M. M. Estabrook, P. Zhou, G. A. Jarvis, and J. M. Griffiss. 1995. Anti-Gal binds to pili of Neisseria meningitidis: the immunoglobulin A isotype blocks complement-mediated killing. Infect. Immun. 63:4900.
35. Salmon, J. E., J. C. Edberg, and R. P. Kimberly. 1996. FcγR on neutrophils. In Human IgG Fc Receptors. J. G. J. van de Winkel and J. A. Capel, eds. Springer-Verlag, Heidelberg, p. 79.
36. Powell, S. M., M. D. Hulett, R. I. Brinkworth, and P. M. Hogarth. 1996. Human FcγR:ligand interactions. In Human IgG Fc Receptors. J. G. J. van de Winkel and J. A. Capel, eds. Springer-Verlag, Heidelberg, p. 5.
37. Stewart, W. W., and M. A. Kerr. 1991. The measurement of respiratory burst induced in polymorphonuclear neutrophils by IgA and IgG anti-gliadin antibodies isolated from coeliac serum. Immunology 73:491.
38. Carayannopoulos, L., J. M. Hexham, and J. D. Capra. 1996. Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between c-α-2 and c-α-3 in human IgAl. J. Exp. Med. 183: 1579.
39. Pleass, R. J., J. I. Dunlop, C. M. Anderson, and J. M. Woof. 1999. Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human Fcα receptor (FcαR) CD89. J. Biol. Chem. 274:23508.
40. Crottet, P., and B. Corthesy. 1999. Mapping the interaction between murine IgA and murine secretory component carrying epitope substitutions reveals a role of domains II and III in covalent binding to IgA. J. Biol. Chem. 274:31456.
41. van Egmond, M., E. van Garderen, A. B. van Spriel, C. A. Damen, E. S. van Amersfoort, G. van Zandbergen, J. van Hattum, J. Kuiper, and, J. G. van de Winkel. 2000. FcαRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nat. Med. 6:680.
42. Plaut, A. G., J. V. Gilbert, M. S. Artenstein, and J. D. Capra. 1975. Neisseria gonorrhoeae and Neisseria meningitidis: extracellular enzyme cleaves human immunoglobulin A. Science 190:1103.